Cargando…

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis

Background. The treatment of chronic inflammatory bowel disease (IBD) is costly, and limited resources call for analyses of the cost effectiveness of therapeutic interventions. The present study evaluated the equivalency of the Short Form 6D (SF-6D) and the Euro QoL (EQ-5D), two preference-based HRQ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huppertz-Hauss, Gert, Aas, Eline, Lie Høivik, Marte, Langholz, Ebbe, Odes, Selwyn, Småstuen, Milada, Stockbrugger, Reinhold, Hoff, Geir, Moum, Bjørn, Bernklev, Tomm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007312/ https://www.ncbi.nlm.nih.gov/pubmed/27630711 http://dx.doi.org/10.1155/2016/5023973

Ejemplares similares

Health-related Quality of Life in Inflammatory Bowel Disease in a European-wide Population-based Cohort 10 Years After Diagnosis
por: Huppertz-Hauss, Gert, et al.
Publicado: (2015)

Pain Severity and Vitamin D Deficiency in IBD Patients
por: Frigstad, Svein Oskar, et al.
Publicado: (2019)

Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients
por: Frigstad, Svein Oskar, et al.
Publicado: (2018)

The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life
por: Opheim, Randi, et al.
Publicado: (2016)

Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
por: Klepp, Pasquale, et al.
Publicado: (2020)

Self-esteem in patients with inflammatory bowel disease
por: Opheim, Randi, et al.
Publicado: (2020)

Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease
por: Jelsness-Jørgensen, Lars-Petter, et al.
Publicado: (2016)

Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year
por: Jelsness-Jørgensen, Lars-Petter, et al.
Publicado: (2011)

Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission
por: Jelsness-Jørgensen, Lars-Petter, et al.
Publicado: (2013)

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
por: van Stel, Henk F, et al.
Publicado: (2006)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study
por: Holten, Kristina I Aass, et al.
Publicado: (2023)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
por: Harrison, M. J., et al.
Publicado: (2009)

Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III)
por: Olsen, Bjorn Christian, et al.
Publicado: (2023)

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
por: Dritsaki, Melina, et al.
Publicado: (2017)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
por: Abdin, Edimansyah, et al.
Publicado: (2021)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway
por: Opheim, Randi, et al.
Publicado: (2022)

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain
por: Barton, Garry R, et al.
Publicado: (2009)

Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China
por: Jin, Hui, et al.
Publicado: (2012)

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
por: Teckle, Paulos, et al.
Publicado: (2013)

Sense of Coherence in Patients with Inflammatory Bowel Disease
por: Opheim, Randi, et al.
Publicado: (2014)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
por: Tawiah, Andrews K., et al.
Publicado: (2019)

A Comparison between the EQ-5D and the SF-6D in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Chen, Jing, et al.
Publicado: (2014)

Multiattribute Glycan Identification and FDR Control for Glycoproteomics
por: Polasky, Daniel A., et al.
Publicado: (2022)

The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
por: Mulhern, Brendan, et al.
Publicado: (2014)

Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China
por: Zhao, Longchao, et al.
Publicado: (2019)

Effect of aerobic exercise intensity on health-related quality of life in severe obesity: a randomized controlled trial
por: Berge, Jarle, et al.
Publicado: (2022)

Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
por: Johansen, Ingunn, et al.
Publicado: (2023)

A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain
por: Ye, Ziping, et al.
Publicado: (2019)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
por: Kontodimopoulos, Nikolaos, et al.
Publicado: (2022)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Clarifying the role of an unavailable distractor in human multiattribute choice
por: Cao, Yinan, et al.
Publicado: (2022)

Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey
por: Kularatna, Sanjeewa, et al.
Publicado: (2019)

Targeting Chemoprevention of Colorectal Cancer to Those Who Are Likely to Respond
por: Stockbrugger, Reinhold W.
Publicado: (2010)

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis
por: Harrison, Mark J, et al.
Publicado: (2010)

Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease
por: Johnsen, Lars G, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dueu5b6ddqcu5m56ebvvuv9ei2